AbbVie Says Recent Antitrust Ruling Irrelevant In Humira Case

By Matthew Perlman · May 20, 2020, 5:28 PM EDT

AbbVie Inc. has told an Illinois federal court that a recent ruling in a case involving speech recognition technology is not relevant whatsoever to Humira buyers' allegations that the pharmaceutical giant...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Humira (Adalimumab) Antitrust Litigation

Case Number

1:19-cv-01873

Court

Illinois Northern

Nature of Suit

410(Anti-Trust)

Date Filed

March 18, 2019